Contact information
Jakub Scaber
Senior Clinical Research Fellow
- Neurology Consultant
Biography
I studied Clinical Medicine at Girton College, Cambridge and St Anne's College, Oxford and graduated in 2009. I did my junior medical training in Oxford and Glasgow, and trained as a neurology registrar in Oxford, Southampton and London. I completed my DPhil in Oxford in 2017 under Professor Kevin Talbot, and became Clinical Lecturer in Oxford in 2018. I have been a Neurology Consultant at Great Western Hospital and Senior Clinical Research Fellow at Oxford University since 2024.
Research Interest
My research aims to understand the biological processes that give rise to motor neuron disease and the related condition of frontotemporal dementia at the cellular and molecular level, specifically using advances in high-throughput sequencing technologies and computational biology to address these questions. I am particularly interested in the development of tools that will allow us to understand why certain cell types are affected by these conditions, whereas others are relatively spared.
I have used pluripotent stem cell-derived neurons to understand how certain pathogenic genetic variants (C9orf72, TDP-43) can predispose certain cell types to the development of motor neuron disease, and have explored the utility of this early neuronal model in the study of an adult neurodegenerative disease in my published research. My current work focuses on the molecular analysis of post-mortem samples using long-read sequencing and other unbiased molecular techniques, and believe that a synergism between these two approaches can yield important insights into the pathophysiology of motor neuron disease. As part of my clinical research I also support the Oxford MND Research Centre with Clinical Trials.
Recent publications
Neurodegenerative disease in C9orf72 repeat expansion carriers: population risk and effect of UNC13A
Journal article
Gao J. et al, (2025), Brain, 148, 3865 - 3871
Dynactin-1 mediates rescue of impaired axonal transport due to reduced mitochondrial bioenergetics in amyotrophic lateral sclerosis motor neurons
Journal article
Dafinca R. et al, (2024), Brain Communications, 6
Cellular and axonal transport phenotypes due to the C9ORF72 HRE in iPSC motor and sensory neurons
Journal article
Scaber J. et al, (2024), Stem Cell Reports, 19, 957 - 972
C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9
Journal article
Vahsen BF. et al, (2023), Nature Communications, 14